Check out this morning's top movers from around Wall Street, compiled by The Fly. 

HIGHER - 

• Clovis Oncology (CLVS) up 15% after the company announced that data from the Phase 3 ARIEL4 study of Rubraca demonstrate that Rubraca significantly improves PFS compared to standard-of-care chemotherapy, including platinum-based chemotherapy, among patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation who have received two or more prior lines of chemotherapy
• Marker Therapeutics (MRKR) up 28% after insider stock purchases and initiation of the stock with an Overweight rating at Cantor Fitzgerald
• FedEx (FDX) up 5% following the company's fiscal Q3 report
• Fisker (FSR) up 12% after announcing it will redeem its outstanding public warrants on a cashless basis

LOWER - 

• Idera Pharmaceuticals (IDRA) down 62% after a drug study miss prompts multiple analyst downgrades
• Skillz (SKLZ) down 9% after its 32M share secondary offering priced at $24 per share
• Nike (NKE) down 2% following the company's fiscal Q3 results, which included a revenue miss